Register now for MPE’s webinar on Evidence-Based Patient AdvocacyMPE, Patient evidence19 October 2020
ASCO and EHA highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, Myeloma, Videos20 July 2020
EHA 2020 – Subcutaneous daratumumab shows improved clinical outcomes in AL amyloidosisAL amyloidosis14 June 2020
FDA Refusal to File letter for Idecabtagene Vicleucel (ide-cel, bb2121) for the treatment of myeloma patientsAccess, Myeloma14 May 2020
